Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Vastra Gotaland Region · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
adherence
antibody-mediated rejection, kidney transplant, chronic rejection, graft function, donor specific antibodies (dsa), transplant-specific well-being, adherence, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1072407
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.